• Global Asthma & COPD Therapies Market forecasts from 2020-2030
• Profiles of the leading 26 asthma & COPD companies: • Adamis Pharmaceuticals Corporation • Aerocrine (Circassia) • ALK-Abello A/S • Amphastar Pharmaceuticals, Inc. • AstraZeneca • Boehringer Ingelheim • Chiesi Farmaceutici • Cipla • Dimerix • GlaxoSmithKline • Innoviva • Lallemand Pharma International • Merck • Mereo BioPharma Group plc • MundiPharma • Novartis • Pulmatrix • Respiratorius AB • Roche • Other companies
• The content of each profile differs, depending on the organization. In general, a profile gives the following information: • An overview and analysis of the company • A portfolio of the company's marketed product and product pipeline • Financial Information • Revenue forecast from 2020-2030 • Recent developments • Future Outlook
• This report discusses factors that drive and restrain the asthma and COPD market.
• Key questions answered by this report: • How is the Asthma & COPD Companies market evolving? • What is driving and restraining the Asthma & COPD Companies market? • What are the market shares of each segment of the overall Asthma & COPD Companies market in 2019? • What will be the main driver for the overall market from 2019 to 2030? • Will leading Asthma & COPD Companies broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • Who are the leading players and what are their prospects over the forecast period? • What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants? • How will the industry evolve during the period between 2019 and 2030?
Did you know that we also offer a report add-on service? Email firstname.lastname@example.org discuss any customized research needs you may have.
Companies covered in the report include:
Aerocrine (Circassia) ALK-Abello A/S American College of Chest Physicians (ACCP) Amphastar Pharmaceuticals, Inc. AstraZeneca Boehringer Ingelheim Chiesi Farmaceutici Ciba-Geigy Cipla Committee for Medicinal Products for Human Use (CHMP) Dainippon Sumitomo Pharma America, Inc. Dermira Inc. European Medicines Agency (EMA) European Respiratory Society (ERS) GlaxoSmithKline (GSK) Glenmark Hikma Innovata plc Innoviva, Inc. Japanese Ministry of Health, Labour and Welfare Lallemand Pharma International Medicines and Healthcare products Regulatory Agency (MHRA) Merck Monitored Therapeutics, Inc. (MTI) MundiPharma Mylan National Institute for Health and Care Excellence (NICE) Novartis Pulmatrix Regeneron Roche Sandoz Sanofi Sepracor Inc. Sorrento Sunovion Teva Theravance Biopharma|Mylan Inc. Torii Vectura Group plc Verona Pharma plc